학술논문

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial
Document Type
Article
Source
In Annals of Oncology September 2020 31(9):1251-1259
Subject
Gynecological tumors
Language
ISSN
0923-7534